Microangiopathic hemolytic anemia as the first manifestation of lung adenocarcinoma
1Department of Physical Medicine and Rehabilitation, State University of New York at Buffalo, USA.
Southern Medical Journal
|May 25, 2001
Abstract:
Anemia is common in patients with disseminated carcinoma and is usually due to bleeding, infection, or marrow suppression from chemotherapy or metastatic infiltration. However, microangiopathic hemolytic anemia is rarely seen in such patients. We report a case in which microangiopathic hemolytic anemia was the initial finding in lung adenocarcinoma.